With the first da Vinci prostatectomy in 2000, urologic surgeons began creating a deep legacy of continuous innovation and collaboration with Intuitive. That legacy generated a track record of positive clinical outcomes through a shared and long-standing belief in robotic urologic surgery.
Today, the evolving needs of urologic surgeons still inspire our drive to innovate beyond multiport robotics. See how the da Vinci SP surgical system enabled single-site entry at different access points in prostatectomy and nephrectomy cases performed by Drs. Kaouk, Ahmed, and Nelson. Also, watch how Dr. Stifelman used the capabilities of the da Vinci Xi surgical system to accomplish a partial nephrectomy.
View our webinars for peer-to-peer learning dedicated to the innovative spirit of urologic surgeons and their journeys with robotics. Hear directly from other surgeons about their experiences with the comprehensive Intuitive ecosystem of systems, learning, services, and digital insights.
Get the latest tips on techniques, expanding your practice, and building programs. Topics include surgeons’ experiences with incorporating both da Vinci Xi and SP into a practice, choosing the right da Vinci system for prostatectomy or nephrectomy, and progressing through the da Vinci SP learning curve.
Important safety information
Serious complications may occur in any surgery, including surgery with a da Vinci system, up to and including death. Examples of serious or life-threatening complications, which may require prolonged and/or unexpected hospitalization and/or reoperation, include but are not limited to, one or more of the following: injury to tissues/organs, bleeding, infection, and internal scarring that can cause long-lasting dysfunction/pain.
Risks specific to minimally invasive surgery, including surgery with a da Vinci system, include but are not limited to, one or more of the following: temporary pain/nerve injury associated with positioning; a longer operative time, the need to convert to an open approach, or the need for additional or larger incision sites. Converting the procedure could result in a longer operative time, a longer time under anesthesia, and could lead to increased complications. Contraindications applicable to the use of conventional endoscopic instruments also apply to the use of all da Vinci instruments.
For important safety information, including surgical risks and considerations, please also refer to www.intuitive.com/safety. For a product’s intended use and/or indications for use, risks, full cautions, and warnings, please refer to the associated user manual(s).
Individual outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or surgeon experience.
Da Vinci SP system
The safety and effectiveness of this device for use in the performance of general laparoscopic surgery procedures have not been established. This device is only intended to be used for single port urological procedures and for transoral otolaryngology surgical procedures in the oropharynx for benign tumors and malignant tumors classified as T1 and T2 with the da Vinci EndoWrist SP instruments and the da Vinci SP surgical system (SP1098).
Da Vinci Xi/X system
The demonstration of safety and effectiveness for the representative specific procedures did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence) or treatment of the patient’s underlying disease/condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.